RxDoctor Payments Data

Alexis Aulisio, NP

Family · Jacksonville Beach, FLNPI 1720326572

Payments from drug & device makers

$1,507in general payments, 2019–2025

Across 78 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$183
  • Novo Nordisk$181
  • Bayer$138
  • Novartis$133
  • Amgen$130
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$85
  • plus $656 from 17 others

What the payments were for

  • Food & beverage$1,507100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,507 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$3,199
Medicare patients
30
Services billed
36

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide13$13,338
OzempicSemaglutide11$12,303
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,881
Levothyroxine Sodium82$853
Divalproex Sodium12$781
Venlafaxine Hcl ErVenlafaxine Hcl26$662
Tizanidine Hcl14$565
Albuterol Sulfate HfaAlbuterol Sulfate39$563
Valsartan11$555
Olanzapine13$544
Zonisamide12$493
Bupropion XlBupropion Hcl12$319
Losartan Potassium46$309
Amlodipine Besylate58$284
Gabapentin27$284

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Olanzapine$73$13,88226 claims
Novo NordiskOzempic$181$12,30311 claims
GSKTrelegy Ellipta$65$9,88114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 14,618 family providers in Florida.

Other family in Jacksonville Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →